Why Johnson & Johnson (JNJ) is a Great Dividend Stock Right Now

Johnson & Johnson (JNJ) is highlighted as a compelling dividend stock, with its shares up 23.72% year-to-date. The company offers an annualized dividend of $5.20 per share, equating to a 2.91% yield, competitive with the Large Cap Pharmaceuticals industry and notably above the S&P 500's average. JNJ has a strong track record of dividend growth, increasing its payout for five consecutive years at an average annual rate of 5.37%, supported by a 52% payout ratio and a projected 8.82% earnings growth for 2025 to $10.86 EPS, making it attractive for income-focused portfolios despite a Zacks Rank #3 (Hold).

Analysis

Johnson & Johnson (JNJ) presents a compelling case for income-focused investors, underpinned by strong dividend metrics and positive forward-looking earnings estimates. The company's stock has appreciated 23.72% year-to-date, and it currently provides a dividend yield of 2.91%, which is nearly double the S&P 500's 1.51% yield and in line with its Large Cap Pharmaceuticals peer group average of 2.94%. The dividend's sustainability is supported by a consistent history of growth, including five increases over the past five years at an average annual rate of 5.37% and a recent 5.9% year-over-year hike. This track record is backed by a healthy payout ratio of 52%, suggesting ample retained earnings for reinvestment. Looking ahead, the Zacks Consensus Estimate for 2025 projects an 8.82% year-over-year earnings growth to $10.86 per share, providing a solid foundation for future dividend increases. Despite these strengths, the stock carries a neutral Zacks Rank of #3 (Hold), and investors should note the stated risk that high-dividend stocks can face headwinds in a rising interest rate environment.

Key Decisions for Investors

• For income-oriented portfolios, Johnson & Johnson warrants consideration as a core holding due to its competitive 2.91% yield, a strong history of dividend growth, and a sustainable 52% payout ratio.
• Investors should weigh the positive fundamentals, such as the projected 8.82% earnings growth, against the neutral Zacks Rank of #3 (Hold), which suggests a hold-and-monitor stance rather than aggressive accumulation.
• It is critical to monitor macroeconomic trends, particularly interest rates, as a rising rate environment could create headwinds for JNJ's stock performance despite its solid operational outlook.